LDS/Medical Tests/Procalcitonin, Serum

Procalcitonin, Serum

Procalcitonin, primarily produced in the thyroid gland, is a protein precursor to calcitonin, which facilitates in calcium and phosphorus metabolism. Proven to be greatly increased in bacterial infections, it serves as a relatively sensitive marker of sepsis. Normally, procalcitonin levels in the blood are very low to nonexistent due to its fast conversion from calcitonin in the thyroid gland. When infection is present, most cells in the body will produce procalcitonin. Procalcitonin production parallels the severity of disease, therefore higher levels will be seen when the disease is more severe. Levels that are decreasing compare closely with effective treatment.

Procalcitonin can aid physicians in the early diagnosis of sepsis, allowing for immediate effective therapy, which also saves time and money for both the patient and facility. An elevated plasma procalcitonin level can be seen in septic patients with normal or decreased white cell counts, and it has been shown to have greater sensitivity when found in conjunction with elevated C-reactive protein and/or erythrocyte sedimentation rate results. Diseases that will display increased procalcitonin levels are bacteremia (bacterial blood infection), bacterial meningitis, lower respiratory infection, pneumonia, and systemic inflammatory response syndrome (SIRS). Procalcitonin has also been shown to be elevated in bacterial infections in patients with chronic renal failure and in patients who develop infections post-surgery.

  • Diagnosis of early sepsis and septic shock and monitoring effect of therapy
  • As an aid in diagnosis of severe systemic infections
  • As an aid in diagnosis of systemic inflammatory response syndrome
  • Differentiate between viral and bacterial infections, especially meningitis and pneumonia
  • Diagnosis of infections post-surgery
  • Evaluate for involvement of the kidney in urinary tract infections in children
  • Help evaluate for bacterial infection in patients who are neutropenic
  • Help evaluate the therapeutic response to antimicrobial therapy

Increased in:

  • Severe bacterial, fungal, and parasite infections such as pneumonia
  • Bacterial Meningitis
  • Systemic bacterial infections such as sepsis, septic shock
  • Systemic Inflammatory Response Syndrome (SIRS)
  • Severe trauma
  • Major burns
  • Multiorgan failure
  • Major surgery
  • Medullary thyroid carcinoma
  • Islet cell tumors of the pancreas
  • Untreated end stage kidney disease may show mild elevation, returns to norma following 3 dialysis treatments.
  • Slight elevation can occur in some infants and childred without identifiable cause

< 0.15 ng/mL
 

 

 

Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (Red top) preferred, or Plasma EDTA (Lavender), Heparin (Green). 

Stability

  • Ambient: 24 hours
  • Refrigerated: 1-3 days
  • Frozen: 30 days
C-Reactive Protein, Blood Culture, CSF Cell Count, CSF Gram Stain, Antistreptolysin (ASO), Erythrocyte Sedimentation Rate, CBC, Sputum Culture, Wound Culture, Urine culture, Renal funtion studies, Liver function studies.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Emerg Med. 2002;20:202. [PMID: 11992340]
  • Clin Infect Dis. 2002;34:895. [PMID: 11880953]
  • Crit Care Med. 2002;30:757. [PMID: 11940741]
  • Crit Care Med. 2006;34:1996. [PMID: 16715031]
  • Ann Emerg Med. 2012 Nov, 60(5):591-600. [PMID: 22921165]
  • Stevens CD. Clinical Immunology & Serology A Laboratory Perspective 3rd edition. Philadelphia: F.A. Davis Company (2010).
  • Procalcitonin, Serum. In Mayo Interpretive Handbook. Rochester: Mayo Medical Laboratories (2009).
  • Revision: Michael Jacewicz, MD. (2009, December). Asceptic Meningitis. Retrieved October 9, 2010, from Merck Manuals Online Library: www.merck.com